Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Heart Valve Disease

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19301552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.

  2008cited by this paper
• Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.

  2008cited by this paper
• 5‐HYDROXYTRYPTAMINE IN THE CARDIOVASCULAR SYSTEM: FOCUS ON THE SEROTONIN TRANSPORTER (SERT)

  2006cited by this paper
• Serotonin transport and serotonin transporter‐mediated antidepressant recognition are controlled by 5‐HT2B receptor signaling in serotonergic neuronal cells

  2006cited by this paper
• Evaluation of glycosaminoglycans content and 5-hydroxytryptamine 2B receptor in the heart valves of Sprague-Dawley rats with spontaneous mitral valvulopathy--a possible exacerbation by dl-amphetamine sulfate in Fischer 344 rats?

  2006cited by this paper
• Pathology of inflammatory native valvular heart disease.

  2006cited by this paper
• Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease.

  2006cited by this paper
• 5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats

  2005cited by this paper
• Long-Term Serotonin Administration Induces Heart Valve Disease in Rats

  2005cited by this paper
• Deficiency of the 5-Hydroxytryptamine Transporter Gene Leads to Cardiac Fibrosis and Valvulopathy in Mice

  2005cited by this paper
• Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease

  2004cited by this paper
• Carcinoid heart disease: presentation, diagnosis, and management

  2004cited by this paper
• Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years.

  2002cited by this paper
• Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

  2002cited by this paper
• Therapeutic and adverse actions of serotonin transporter substrates.

  2002cited by this paper
• Serotonin activation of the ERK pathway in Hermissenda: contribution of calcium‐dependent protein kinase C

  2001cited by this paper
• Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.

  2001cited by this paper
• Mitral valve prolapse in the dog: a model of mitral valve prolapse in man.

  2000cited by this paper
• Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves.

  2000cited by this paper
• 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.

  2000cited by this paper
• Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

  2000cited by this paper
• MAP kinase pathways.

  1999cited by this paper
• TGF-beta receptors and signalling mechanisms.

  1998cited by this paper
• Valvular heart disease associated with fenfluramine-phentermine.

  1997cited by this paper
• Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.

  1995cited by this paper
• International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

  1994cited by this paper
• Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells

  1993cited by this paper
• Transforming growth factor-beta.

  1992cited by this paper

• Involvement of TGF-β, mTOR, and inflammatory mediators in aging alterations during myxomatous mitral valve disease in a canine model

  2025cites this paper
• Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation

  2023cites this paper
• Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease

  2023cites this paper
• TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease

  2023cites this paper
• The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration

  2022cites this paper
• Telotristat ethyl reverses myxomatous changes in mice mitral valves

  2022cites this paper
• Characterization of the spontaneous degenerative mitral valve disease in FVB mice

  2021cites this paper
• Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease

  2021cites this paper
• Genetics of canine myxomatous mitral valve disease.

  2021cites this paper
• Increased release of serotonin from rat primary isolated adult cardiac myofibroblasts

  2021cites this paper
• Comparison of Serotonin-Regulated Calcific Processes in Aortic and Mitral Valvular Interstitial Cells

  2021cites this paper
• Comparative transcriptomic pro ling of myxomatous mitral valve disease in the Cavalier King

  2020cites this paper
• Inhibition and down regulation of the serotonin transporter contribute to the progression of degenerative mitral regurgitation

  2020cites this paper
• Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

  2020cites this paper
• The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease

  2020cites this paper
• Disease Severity-Associated Gene Expression in Canine Myxomatous Mitral Valve Disease Is Dominated by TGFβ Signaling

  2020cites this paper
• Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel

  2020cites this paper
• Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration

  2019cites this paper
• Survival of activated myofibroblasts in canine myxomatous mitral valve disease and the role of apoptosis.

  2019cites this paper
• Ontogeny of canine myxomatous mitral valve disease; cellular and molecular events over a lifetime

  2019influential citation
• Polymorphism in the serotonin transporter protein gene in Maltese dogs with degenerative mitral valve disease

  2018cites this paper
• Interbreed variation in serum serotonin (5-hydroxytryptamine) concentration in healthy dogs.

  2018cites this paper
• Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.

  2018influential citation
• Serotonergic 5-HT 2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors

  2018cites this paper
• Detection of transforming growth factor beta 1 in normal dogs and dogs with degenerative mitral valve disease

  2018cites this paper
• The role of 5‐HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors

  2017cites this paper
• MicroRNAs in veterinary cardiology

  2017cites this paper
• Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human

  2017cites this paper
• Myxomatous Degeneration of the Canine Mitral Valve: From Gross Changes to Molecular Events.

  2017influential citation
• Pathophysiology of Aortic Stenosis and Mitral Regurgitation.

  2017cites this paper
• MicroRNAs in veterinary cardiology MicroRNAs em cardiologia veterinária

  2017cites this paper
• A survey of membrane receptor regulation in valvular interstitial cells cultured under mechanical stresses

  2017cites this paper
• Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis

  2017cites this paper
• Production and Function of Serotonin in Cardiac Cells

  2017cites this paper
• valvesn synthesis in cultured sheep mitral transformation, matrix degradation, and Local serotonin mediates cyclic strain-induced phenotype

  2016cites this paper
• [Ovarian carcinoid tumor responsible of permanent facial erythrosis and flushings during sexual intercourse].

  2016cites this paper
• Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease.

  2016cites this paper
• Tumeur carcinoïde ovarienne responsable d’une érythrose faciale permanente et de flushs au décours des coïts

  2016cites this paper
• Serotonin markers show altered transcription levels in an experimental pig model of mitral regurgitation.

  2015cites this paper
• Increased endogenous serotonin level in diabetic conditions may lead to cardiac valvulopathy via reactive oxygen species regulation

  2015cites this paper
• Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease

  2015cites this paper
• Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.

  2015cites this paper
• Connecting Structural Changes to Cell Transformation Patterns in the Canine Degenerative Mitral Valve

  2015cites this paper
• Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.

  2015cites this paper
• Serum serotonin concentration in small breed dogs with degenerative mitral valve disease

  2015cites this paper
• Serotonin Concentrations in Platelets, Plasma, Mitral Valve Leaflet, and Left Ventricular Myocardial Tissue in Dogs with Myxomatous Mitral Valve Disease

  2014cites this paper
• Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.

  2014influential citation
• Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease.

  2014cites this paper
• Tissue-engineered canine mitral valve constructs as In vitro research models for myxomatous mitral valve disease

  2014cites this paper
• The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy.

  2014cites this paper
• Role of inflammation and extracellular matrix remodelling in dogs with cardiac and systemic diseases

  2013cites this paper
• Human Myxomatous Mitral Valves Exhibit Focal Expression of Cartilage-related Proteins

  2013cites this paper
• Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.

  2013cites this paper
• Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.

  2013cites this paper
• Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.

  2013cites this paper
• Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).

  2013cites this paper
• The Mechanics And Molecular Regulation Of Heart Valve Morphogenesis

  2012influential citation
• Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.

  2012cites this paper
• Local serotonin mediates cyclic strain-induced phenotype transformation, matrix degradation, and glycosaminoglycan synthesis in cultured sheep mitral valves.

  2012cites this paper
• Serotonin Potentiates Transforming Growth Factor-beta3 Induced Biomechanical Remodeling in Avian Embryonic Atrioventricular Valves

  2012cites this paper
• Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.

  2012influential citation
• Developmental basis for filamin-A-associated myxomatous mitral valve disease.

  2012cites this paper
• Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves.

  2012cites this paper
• Correction: Serotonin Potentiates Transforming Growth Factor-beta3 Induced Biomechanical Remodeling in Avian Embryonic Atrioventricular Valves

  2012cites this paper
• Signaling pathways in mitral valve degeneration.

  2012cites this paper
• Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture.

  2012cites this paper
• Cardiovascular oxidative stress: recent findin gs on ACE2 And MAO

  2012cites this paper
• Aortic valve disease and treatment: the need for naturally engineered solutions.

  2011cites this paper
• Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness.

  2011cites this paper
• Inflammatory Regulation of Valvular Remodeling: The Good(?), the Bad, and the Ugly

  2011cites this paper
• Perinatal Changes in Mitral and Aortic Valve Structure and Composition

  2010cites this paper
• Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease.

  2010cites this paper
• Composition, turnover, and mechanics of extracellular matrix in developing, aging, and pathological valves for application in the design of age-specific tissue engineered heart valves

  2010cites this paper
• Myxomatous Degenerative Mitral Valve Disease: An Update

  2010influential citation
• Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.

  2010cites this paper
• Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease.

  2010cites this paper
• Differential protein expression between normal, early‐stage, and late‐stage myxomatous mitral valves from dogs

  2009cites this paper
• Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves.

  2009cites this paper
• Serum Serotonin Concentrat ions in Dogs with Degenerative Mitral Valve Disease

  2009cites this paper
• Serum Serotonin C oncentrations in Dogs with Degenerative Mitral Valve Disease

  2009cites this paper
• Serum serotonin concentrations in dogs with degenerative mitral valve disease.

  2009cites this paper